9068 Results

Journal Article

Quality of life, HPV-status and phase angle predict survival in head and neck cancer patients under (chemo)radiotherapy undergoing nutritional intervention: Results from the prospective randomized HEADNUT-trial

Authors: Laura Magdalena Kutz, Jakob Abel, Diana Schweizer, Silke Tribius, Andreas Krüll, Cordula Petersen, Anastassia Löser

Congress Abstract

High frame rate CAIPIRINHA-TWIST-VIBE MRI for volumetric motion monitoring in MRgRT: a pilot study

Authors: Yuan|, Jing(1)*[jyuanbwh@gmail.com];Wong|, Oi Lei(1);Ho|, Ruby Y.W.(1);Zhou|, Yihang(1);Cheung|, Kin YIn(1);Yu|, Siu KI(1);
(1)Hong Kong Sanatorium & Hospital, Medical Physics and Research Department, Happy Valley, Hong Kong SAR China;
Show Affiliations

Congress Abstract

Hypofractionated radiotherapy for breast cancer: Findings from an international ESTRO-GIRO survey

Authors:

Melinda Mushonga1,2, Jessica Weiss 3, Amy Zhihui Liu4,5, Osama Mohamad 6, Yolande Lievens 7, Danielle Rodin1, Danielle Rodin8

1Princess Margaret Cancer Center, Radiation Oncology, Toronto, Canada; 2Sally Mugabe Hospital, Department of Oncology, Harare, Zimbabwe; 3 Princess Margaret Cancer Centre, Department of Biostatistics, Toronto, Canada; 4Princess Margaret Cancer Centre, Department of Biostatistics, Toronto, Canada; 5Dalla Lana School of Public Health, University of Toronto, Biostatistics, Toronto, Canada; 6 University of California , , Department of Radiation Oncology, San Francisco, USA; 7Ghent University Hospital and Ghent University, Department of Radiation Oncology, Ghent, Belgium; 8University of Toronto, Radiation Oncology Program, Toronto, Canada

Show Affiliations

Congress Abstract

Treatment planning considerations in particle therapy

Authors: Kristensen|, Ingrid(1)*[ingrid.kristensen@skane.se];
(1)Skåne University Hospital, Dept of Hemathology- Oncology and Radiation Physics, Lund, Sweden;
Show Affiliations

Congress Abstract

Feasibility and first experience of MR-guided adaptive radiotherapy for head and neck cancer

Authors: Balermpas|, Panagiotis(1)*[Panagiotis.Balermpas@usz.ch];Krayenbühl|, Jerome (1);Chamberlain|, Madalyne(1);Bogowicz|, Marta(1);Garcia-Schüler|, Helena I.(1);Andratschke|, Nicolaus(1);Moreira|, Amanda K.(1);Wilke|, Lotte(1);Tanadini-Lang|, Stephanie(1);Guckenberger|, Matthias(1);
(1)University Hospital Zurich, Radiation-Oncology, Zurich, Switzerland;
Show Affiliations

Journal Article

Patient specific outcomes of charged particle therapy for hepatocellular carcinoma – A systematic review and quantitative analysis

Authors: Piotr Spychalski, Jarek Kobiela, Magdalena Antoszewska, Agata Błażyńska-Spychalska, Barbara A. Jereczek-Fossa, Morten Høyer

Journal Article

The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies

Authors: Richard Pötter, Kari Tanderup, Christian Kirisits, Astrid de Leeuw, Kathrin Kirchheiner, Remi Nout, Li Tee Tan, Christine Haie-Meder, Umesh Mahantshetty, Barbara Segedin, Peter Hoskin, Kjersti Bruheim, Bhavana Rai, Fleur Huang, Erik Van Limbergen, Max Schmid, Nicole Nesvacil, Alina Sturdza, Lars Fokdal, Nina Boje Kibsgaard Jensen, Dietmar Georg, Marianne Assenholt, Yvette Seppenwoolde, Christel Nomden, Israel Fortin, Supriya Chopra, Uulke van der Heide, Tamara Rumpold, Jacob Christian Lindegaard, Ina Jürgenliemk-Schulz

Congress Abstract

Quantification and reduction of susceptibility artefacts for a quality assurance phantom in MRgRT

Authors: Hellwich , Emily(1,2)*[emily@hellwich.me];Elter , Alina(2,3,4);Dorsch , Stefan(2,3,4);Mann , Philipp(3,4);Emmerich , Julian(2,5);Schäfer , Martin(6);Runz , Armin(3,4);Klüter , Sebastian(4,7);Spindeldreier , C. Katharina(4,7);Karger , Christian P.(4,8);Debus , Jürgen(1,4,7,9,10,11); Geist, Jeschua(12);
(1)German Cancer Research Center DKFZ, Clinical Cooperation Unit Radiation Oncology, Heidelberg, Germany;(2)University of Heidelberg, Faculty of Physics and Astronomy, Heidelberg, Germany;(3)German Cancer Research Center DKFZ, Medical Physics in Radiation Oncology, Heidelberg, Germany;(4)Heidelberg Institute of Radiation Oncology HIRO, National Center for Radiation Research in Oncology NCRO, Heidelberg, Germany;(5)German Cancer Research Center DKFZ, Division of Medical Physics in Radiology, Heidelberg, Germany;(6)German Cancer Research Center DKFZ, Department of Radiopharmaceutical Chemistry, Heidelberg, Germany;(7)University Hospital Heidelberg, Department of Radiation Oncology, Heidelberg, Germany;(8)German Cancer Research Center, Medical Physics in Radiation Oncology, Heidelberg, Germany;(9)German Cancer Consortium DKTK, partner site, Heidelberg, Germany;(10)Heidelberg Ion-Beam Therapy Center HIT- Heidelberg University Hospital, Department of Radiation Oncology, Heidelberg, Germany;(11)National Center for Tumor diseases NCT, Radiation Oncology and Radiation Therapy, Heidelberg, Germany; (12)Kirchhoff-Institute for Physics, Heidelberg University, Heidelberg,Germany
Show Affiliations

Journal Article

Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO)

Authors: Pierluigi Bonomo, Isacco Desideri, Mauro Loi, Monica Mangoni, Mariangela Sottili, Livia Marrazzo, Cinzia Talamonti, Daniela Greto, Stefania Pallotta, Lorenzo Livi

Congress Abstract

Risk for radiation-induced cancer following proton vs.photon radiotherapy of mediastinal lymphoma

Authors: König|, Laila(1)*[laila.koenig@med.uni-heidelberg.de];Haering|, Peter(2);Lang|, Clemens(2);von Nettelbladt|, Bastian(1);Weykamp|, Fabian(1);Hoegen|, Philipp(1);Susko|, Matthew(3);Herfarth|, Klaus(1);Debus|, Jürgen(1);Hörner-Rieber|, Juliane(1);
(1)University Hospital Heidelberg, Department of Radiation Oncology, Heidelberg, Germany;(2)German Cancer Research Center DKFZ- Heidelberg- Germany, Clinical Cooperation Unit Radiation Oncology, Heidelberg, Germany;(3)University of California – San Francisco, Department of Radiation Oncology, San Francisco, USA;
Show Affiliations
*:*